BCH names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Lyophilisation
We set out what is known, what is inferred and what is simply assumed about the fortnight after a vial is opened.
Reconstitution is the point at which a stable product becomes a perishable one, and the change is not incremental. Deamidation, hydrolysis and disulphide exchange all require water as a participant or a medium; aggregation requires molecular mobility that the dried matrix denies. Adding two millilitres of diluent restores all of it at once. The consequence is that a product with a two-year shelf life as a cake may have an in-use period measured in weeks, and the second figure is not derivable from the first by any calculation.
We ordered nine parcels of lyophilised material at catalogue prices, as ordinary customers, from suppliers we did not identify ourselves to, and arranged for a calibrated logger to travel inside the insulated payload of each. Eight arrived and produced complete traces. The ninth was held at a border for eleven days, exhausted its memory on day five, and arrived with a partial record and a cake that had visibly shrunk.
The headline results are in the table below. Transit times ran from two to nine days against quoted estimates of three to five. Five of the eight complete traces exceeded twenty-five degrees at some point; three exceeded thirty; the maximum recorded was thirty-eight degrees for three hours and forty minutes on a road leg. Mean kinetic temperature exceeded the arithmetic mean in every case, by between one and six degrees, with the largest gap on the trace with the shortest and hottest excursion — which is precisely the pattern the calculation is designed to expose.
Two of the eight arrived with their coolant packs still partly frozen, both on two-day domestic journeys. On the six longer journeys the coolant had fully melted and equilibrated, in most cases before the halfway point of the trip. We regard that as the central finding: for anything beyond about forty-eight hours, the gel pack is a delay rather than a control, and the shipment is relying on the material tolerating ambient temperature.
The freeze-thaw cycle is harder on a reconstituted solution than a steady temperature several degrees higher, because each cycle concentrates solutes at the ice interface. The freezer door is the worst location in a domestic kitchen and the one most often used.
Our ninth parcel entered a customs facility on a Thursday and left it eleven days later, released without explanation and without any record of the conditions in between. The logger, configured with a memory sufficient for a five-day journey at five-minute sampling, stopped recording on day five with the temperature at twenty-two degrees and rising through the afternoon. What happened over the following six days is unknown and cannot be reconstructed.
This is the least documented step in the supply chain and, when it occurs, routinely the longest. Examination facilities are not temperature-controlled, dwell time is not committed to, and neither shipper nor recipient receives a record. It follows that any claim of end-to-end temperature control on an international parcel of this kind cannot be true, because there is a segment during which nobody is measuring and nobody has authority to intervene.
The Journal reports this as a structural feature rather than a scandal. Customs authorities are performing a lawful function and are under no obligation to preserve the thermal history of a research chemical. But the consequence deserves to be stated plainly, because it is stated nowhere else: for a cross-border shipment, the shipper controls the first leg, the carrier controls the second, and there is a third leg over which nobody has visibility at all. Buyers reasoning about cold chain should reason about that leg.
The aggregate arrives at the column, comes apart, and is recorded as monomer.
Callum Brathwaite, Analytical Chemistry CorrespondentIn-use stability is established by a dedicated study: the finished product reconstituted as intended, at the intended concentration, in the intended container, stored at the intended temperature, sampled at intervals, and analysed by stability-indicating methods for related substances and by a size-based method for aggregates. The output is a period, and the period belongs to that formulation in that container and to nothing else.
The in-use periods circulating in this market are not derived that way. They are, in the Journal’s experience of tracing them, borrowed from the labelling of marketed pen presentations, which are different formulations at different concentrations with different preservative systems in different primary containers. Marketed in-use periods for the incretin pens run from four weeks to eight depending on product and storage condition, and none of those figures transfers to a reconstituted research vial by any argument we can construct.
What can be said generally is directional rather than numerical. Degradation in solution proceeds orders of magnitude faster than in the cake. Lower temperature helps substantially. Repeated warming and cooling of an opened vial is worse than steady storage. Preservative-containing diluent addresses microbial growth and does nothing about chemical degradation. And in the absence of a study on the actual product, any specific number quoted for an in-use period is an assumption wearing a specification’s clothes.
One further loss is routinely mistaken for degradation. Peptides adsorb to glass and polymer surfaces, and the relationship runs the awkward way: the more dilute the solution, the larger the proportion a given surface area removes.1
| Pathway | Residues at risk | Accelerated by | Mass change | Detected by |
|---|---|---|---|---|
| Deamidation | Asn (fast at Asn-Gly), Gln | Water, pH above neutral, heat | None (isoAsp) or +1 Da | Shallow RP gradient; isoAsp-specific methods |
| Oxidation | Met, Trp, His, Cys, Tyr | Peroxides, trace metals, light, oxygen | +16 Da and multiples | LC–MS; RP shift |
| Aggregation | Sequence-dependent | Interfaces, shaking, freeze-thaw | Multiples of monomer | Size-exclusion; light scattering |
| Hydrolysis | Asp-Pro, Asp-Gly, N-terminal Gln | Low pH, heat, water | Fragments | RP-HPLC and MS on fragments |
| Racemisation | Asp, Ser, Cys | Heat, extremes of pH | None | Chiral or highly discriminating RP methods |
| Sequence dependence is the rule. This table describes tendencies across peptides, not the behaviour of any particular molecule, and the mass-change column is the reason identity confirmation by molecular ion alone is insufficient for stability purposes. | ||||
Sterile water for injection contains water and nothing else. It is sterile when the container is opened and it has no capacity to remain so, and it supports the growth of any organism introduced subsequently. It is the appropriate diluent for a single-use presentation and the wrong one for anything intended to be entered more than once.
Bacteriostatic water for injection contains benzyl alcohol at nine parts per thousand. Benzyl alcohol inhibits microbial growth, which is what makes a multiple-dose presentation coherent, and it is important to be exact about what that means: a preservative suppresses the proliferation of organisms introduced during use. It does not sterilise a contaminated solution, it does not act instantly, and its effectiveness against a given organism is established by a specific compendial test rather than assumed.
Two further points get lost. Benzyl alcohol is not universally compatible; it has been implicated in the aggregation of certain protein formulations, and compatibility with a given peptide is a question for data rather than for convention. And a preservative system has its own stability: preservative content declines over an in-use period, which is one of the attributes a proper in-use study measures. A diluent choice is therefore a formulation decision with chemical consequences, not a matter of preference between two clear liquids.2
Freezing a reconstituted vial to extend its life is a common inference and a poor one, for reasons that have nothing to do with temperature and everything to do with what happens during the phase change. As ice forms, solutes are excluded from the crystal lattice and concentrated into a shrinking unfrozen fraction. Local concentration, ionic strength and pH in that fraction can shift dramatically — buffer components crystallise at different points, and a phosphate buffer is notorious for a large pH excursion on freezing.
The ice-water interface is itself a denaturing surface, and interfacial area increases with the number of freeze-thaw cycles. Each cycle presents the peptide with a fresh opportunity to unfold at that interface and aggregate. This is why formulations intended for frozen storage contain cryoprotectants and why lyophilisation exists as a technique at all: the point of drying is to avoid keeping a peptide in a partially frozen aqueous system.
The Journal states the mechanism and declines the recommendation, as this department’s practice requires. What can be said without advising anybody is that freezing a reconstituted solution is a different chemical operation from freezing a dried cake, that its effects are formulation-dependent and not predictable from first principles, and that no in-use study we have seen in this market has examined it. A reader treating the freezer as a pause button is relying on an assumption nobody has tested for that product.
Residual moisture is the cheapest determination in this whole subject and the most predictive of shelf life, and it appears on almost no certificate. A cake at one per cent water and a cake at four behave quite differently over a year at the same temperature.
The regulatory framework in this article is taken from the harmonised guidelines on stability testing and on biotechnological products, read in the original, and from the current compendial chapters on storage definitions, distribution of temperature-sensitive products and stability in dispensing practice. The degradation chemistry is drawn from the peptide and pharmaceutical sciences literature, and where a claim is a generalisation across sequences this piece says so, because sequence dependence is the rule rather than the exception.
The shipment data is ours. Nine parcels, ordered at catalogue prices as ordinary customers, with calibrated loggers placed inside the insulated payload and sampling at five-minute intervals. Eight complete traces and one truncated by a customs hold. We disclose that nine parcels is not a survey, that we did not control the packing operation, and that a single logger cannot characterise a payload with a thermal gradient across it.
Nothing in this department is a recommendation about storing, reconstituting or administering anything. The compounds discussed are sold for research use only and are not approved for human use in any jurisdiction. Corrections and disputes go to standards@compoundjournal.com; documents, traces and certificates readers would like examined go to letters@compoundjournal.com, and we do not identify the source of anything sent to us.
The customs leg remains the part of this story we cannot report properly, and it deserves saying every time the subject comes up: there is a segment of every cross-border journey during which nobody measures and nobody has authority to intervene. Any claim of end-to-end control across that segment is a claim about something unobserved.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
Labelling the date of reconstitution on the vial is the single practice that would improve this most, and it requires a marker pen. Half the uncertainty in these discussions is uncertainty about how long something has been sitting.
— Q. Delacroix, Montréal, QC
Bacteriostatic diluent contains a preservative and is intended for multiple withdrawals; sterile water is not. That distinction is the one thing in this whole subject that a supplier could usefully print on the box, and I have never seen it printed. Research-use material is not approved for human use in any event, and the storage physics is the same either way.
— C. Aguirre, Rosario
The distinction is real and the reason for it is microbiological rather than chemical, which is why it belongs beside the sterility material rather than the degradation chemistry.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a verification mark would have to carry to be checkable: a date, a lot, a method, a submitter and a link to the report.
Skin thickness at the standard injection sites is approximately two millimetres in adults and varies remarkably little with body mass. That single finding is why short…
We describe each pathway in enough chemical detail to explain why it is invisible to the method the trade uses, because that is the part which has practical consequences.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.